Thousands demand NHS halt use of patient data on Palantir platform
Objectors claim Palantir undermines public confidence in the confidentiality of patient data
More than 44,000 people have filed legal objections to prevent the NHS from using their health records on a data platform powered by US technology company Palantir.
The objections, coordinated by the not-for-profit organisation 38 Degrees, call on NHS England to stop sharing, storing or processing the individuals' data through its Federated Data Platform (FDP).
The campaigners invoke Article 21 of the UK General Data Protection Regulation (GDPR), which gives individuals the right to object to the processing of their personal information.
Under the law, organisations must stop processing data unless they can demonstrate compelling legitimate grounds for continuing.
The objectors have also asked the NHS to suspend processing their information while it considers their requests.
They argue that Palantir's involvement undermines public confidence in the confidentiality of NHS patient data.
Veronica Hawking, campaigns director at 38 Degrees, said the scale of the objections should prompt the government to reconsider its approach.
Health charity MedAct said more than 85,000 patients had submitted formal complaints to their hospitals.
David Murray, a retired IBM systems engineer, requested that his data be blocked, stating he supported the NHS collecting comprehensive patient information but wanted assurances about how it would be used.
NHS England said it would address the objections in line with data protection legislation.
"All NHS organisations remain in control of their data within the FDP, with suppliers unable to access it for their own purposes," it told the Guardian.
Palantir said it processed patient information only on the NHS's instructions and that the data remained in the UK.
The company defended the platform's contribution to healthcare, stating it had helped NHS trusts deliver 117,000 additional operations, cut long-stay patient discharge delays by 14.3% and improve 28-day cancer diagnosis rates by 5.6%.
Questions over NHS performance claims
Palantir's performance figures have faced scrutiny from the Office for Statistics Regulation (OSR), which has urged NHS England to communicate the platform's reported benefits more carefully.
The regulator said NHS England had added a caveat to its published figures on 6th June, acknowledging that it could not establish a direct causal link between the platform and reported improvements because other variables had not been controlled for.
Tom Watson, Palantir's newly appointed UK senior vice-president and a former Labour deputy leader, criticised Labour MP Clive Lewis for making what he called "inaccurate claims" about Palantir' work in healthcare, policing and defence.
Watson, who had advised Palantir since 2024 before joining full-time last month, challenged Lewis in a detailed letter.
Watson said the FDP was operational at 142 NHS trusts, with 137 reporting benefits.
However, data obtained by campaign group Foxglove showed that 13 of the 41 trusts using the FDP-based system performed fewer operations after its introduction, despite an overall reported increase of 111,589 procedures.
Watson's letter to Lewis did not include the OSR's caveat about the limitations of the NHS performance figures.
Palantir secured the lead role in the NHS data platform project in November 2023 under a £330 million, seven-year contract.
The initial term is due to end early next year, when the government can either invoke a break clause or extend the agreement.
The government is expected to decide on the contract in the coming months.